Filmarray respiratory panel 2

Manufactured by bioMérieux

Sourced in Japan

The FilmArray Respiratory Panel 2.1 is a molecular diagnostic test that simultaneously detects and identifies multiple respiratory pathogens, including viruses and bacteria, from a single patient sample. The panel is designed to provide rapid and comprehensive results to aid in the diagnosis of respiratory infections.

Automatically generated - may contain errors

Lab products found in correlation

Viral transport media, by Copan (1 mentions) Filmarray torch system, by bioMérieux (1 mentions) Genexpert, by Cepheid (1 mentions) Lumipulse g600ii system, by Fujirebio (1 mentions)

2 protocols using filmarray respiratory panel 2

SARS-CoV-2 RT-qPCR Screening and Co-infections

Check if the same lab product or an alternative is used in the 5 most similar protocols

SARS-CoV-2 RT-qPCR was performed at officially approved laboratories, including the University of Toyama, Toyama Institute of Health, and external private laboratories. The RT-qPCR varied by laboratory. Cases of RNAemia were screened (31 (link)), with the results used as the demographic background. When the remaining respiratory specimens were available, co-infecting microorganisms were screened using the FilmArray Respiratory Panel 2.1 (bioMérieux Japan, Tokyo, Japan), according to the manufacturer’s instructions.

Morinaga Y., Tani H., Terasaki Y., Nomura S., Kawasuji H., Shimada T., Igarashi E., Saga Y., Yoshida Y., Yasukochi R., Kaneda M., Murai Y., Ueno A., Miyajima Y., Fukui Y., Nagaoka K., Ono C., Matsuura Y., Fujimura T., Ishida Y., Oishi K, & Yamamoto Y. (2021). Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants. Microbiology Spectrum, 9(3), e00560-21.

+ Open protocol

+ Expand

Multimodal SARS-CoV-2 Detection Protocols

Cited 3 times

Check if the same lab product or an alternative is used in the 5 most similar protocols

Nasopharyngeal swab samples were collected using cotton swabs and placed in viral transport media (Copan Diagnostics, Murrieta, CA, USA). Multiple molecular diagnostic testing platforms, including SARS-CoV-2 quantitative reverse transcriptase-PCR in accordance with the protocol developed by the National Institute of Infectious Diseases in Japan (Shirato et al., 2020 (link)), FilmArray Respiratory Panel 2.1 with the FilmArray Torch system (bioMérieux, Marcy-l'Etoile, France) (Hirotsu et al., 2020a (link)), Xpert Xpress SARS-CoV-2 test using Cepheid GeneXpert (Cepheid, Sunnyvale, CA, USA) (Hirotsu et al., 2022 (link)), and Lumipulse antigen test with the LUMIPULSE G600II system (Fujirebio, Inc., Tokyo, Japan) were used to identify positive samples for this study (Hirotsu et al., 2021 (link); Hirotsu et al., 2020b ).

Hirotsu Y., Maejima M., Shibusawa M., Natori Y., Nagakubo Y., Hosaka K., Sueki H., Mochizuki H., Tsutsui T., Kakizaki Y., Miyashita Y, & Omata M. (2022). Classification of Omicron BA.1, BA.1.1, and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data. International Journal of Infectious Diseases, 122, 486-491.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!